Baxter International Inc. (NYSE:BAX) announced that Alok Sonig, Executive Vice President and Group President, Pharmaceuticals, notified the company on November 5 of his decision to resign. According to a statement based on a recent SEC filing, Sonig’s resignation will be effective December 1. The company reported that Sonig is leaving to join another organization in the healthcare industry.
No additional details regarding Sonig’s future role or Baxter International’s plans for his replacement were disclosed in the filing. The information is based on a press release statement included in the company’s Form 8-K filed with the Securities and Exchange Commission.
In other recent news, Baxter International Inc. reported its third-quarter 2025 earnings, revealing an earnings per share (EPS) of $0.69, which surpassed the forecasted $0.60. However, the company’s revenue came in at $2.84 billion, slightly below the expected $2.88 billion. This mixed performance has led to adjustments in analyst expectations. S&P Global Ratings downgraded Baxter International to ’BBB-’ from ’BBB’, citing ongoing challenges affecting revenue growth and profitability. Additionally, TD Cowen and Stifel both lowered their price targets for the company to $22, maintaining a Hold rating due to continued business pressures and guidance cuts. Baxter’s third-quarter revenue of $2.82 billion showed 2% operational growth, but this was below the company’s guidance of 3-4%. The company has also announced a reduction in its quarterly dividend to $0.01 per share, representing a significant decrease from previous levels. These developments reflect the headwinds Baxter is facing in its operational and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
ProPicks AI evaluates BAX alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if BAX is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?